Mechanisms of rejection in vascular composite allotransplantation

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Current Opinion in Organ Transplantation

• Publication date

  2017-11-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1097/MOT.0000000000000490PMID 29189293
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• OPTN/SRTR 2015 Annual Data Report: Kidney

  2017cited by this paper
• Suppression of allograft rejection by CD8+CD122+PD-1+ Tregs is dictated by their Fas ligand-initiated killing of effector T cells versus Fas-mediated own apoptosis

  2017cited by this paper
• In vivo induction of regulatory T cells promotes allergen tolerance and suppresses allergic contact dermatitis

  2017cited by this paper
• Face Transplantation: Partial Graft Loss of the First Case 10 Years Later

  2017cited by this paper
• The Influence of Timing and Frequency of Adipose-Derived Mesenchymal Stem Cell Therapy on Immunomodulation Outcomes After Vascularized Composite Allotransplantation

  2017cited by this paper
• Capillary Thrombosis in the Skin: A Pathologic Hallmark of Severe/Chronic Rejection of Human Vascularized Composite Tissue Allografts?

  2016cited by this paper
• Impact of Early Blood Transfusion After Kidney Transplantation on the Incidence of Donor‐Specific Anti‐HLA Antibodies

  2016cited by this paper
• Vascularized composite allotransplantation: a closer look at the banff working classification

  2016cited by this paper
• Chronic Rejection in Human Vascularized Composite Allotransplantation (Hand and Face Recipients): An Update.

  2016cited by this paper
• Vascularized composite allograft‐specific characteristics of immune responses

  2016cited by this paper
• Combined Anti‐CD154/CTLA4Ig Costimulation Blockade‐Based Therapy Induces Donor‐Specific Tolerance to Vascularized Osteomyocutaneous Allografts

  2016cited by this paper
• Hand and Upper Extremity Transplantation: An Update of Outcomes in the Worldwide Experience

  2015cited by this paper
• The Potential of GMP-Compliant Platelet Lysate to Induce a Permissive State for Cardiovascular Transdifferentiation in Human Mediastinal Adipose Tissue-Derived Mesenchymal Stem Cells

  2015cited by this paper
• Preventing Allograft Rejection by Targeting Immune Metabolism.

  2015cited by this paper
• Anti‐HLA sensitization in extensively burned patients: extent, associated factors, and reduction in potential access to vascularized composite allotransplantation

  2015cited by this paper
• Outcomes after bilateral hand allotransplantation: a risk/benefit ratio analysis.

  2015cited by this paper
• Clinicopathological Findings of Chronic Rejection in a Face Grafted Patient

  2015cited by this paper
• Rapamycin and CTLA4Ig Synergize to Induce Stable Mixed Chimerism Without the Need for CD40 Blockade

  2015cited by this paper
• Differentiation between Acute Skin Rejection in Allotransplantation and T-Cell Mediated Skin Inflammation Based on Gene Expression Analysis

  2015cited by this paper
• Adipose‐Derived Stromal Cells Promote Allograft Tolerance Induction

  2014cited by this paper
• Antibody‐mediated rejection in hand transplantation

  2014cited by this paper
• Long‐Term Results in Recipients of Combined HLA‐Mismatched Kidney and Bone Marrow Transplantation Without Maintenance Immunosuppression

  2014cited by this paper
• Graft vasculopathy in the skin of a human hand allograft: implications for diagnosis of rejection of vascularized composite allografts

  2014cited by this paper
• Simultaneous Transplantation of Hematopoietic Stem Cells and a Vascularized Composite Allograft Leads to Tolerance

  2014cited by this paper
• The Management of Antibody‐Mediated Rejection in the First Presensitized Recipient of a Full‐Face Allotransplant

  2014cited by this paper
• Successful Transplantation of Kidney Allografts in Sensitized Rats After Syngeneic Hematopoietic Stem Cell Transplantation and Fludarabine

  2014cited by this paper
• Stable mixed hematopoietic chimerism permits tolerance of vascularized composite allografts across a full major histocompatibility mismatch in swine

  2014cited by this paper
• Biomarker evaluation of face transplant rejection: association of donor T cells with target cell injury

  2014cited by this paper
• Lymphoid neogenesis in skin of human hand, nonhuman primate, and rat vascularized composite allografts

  2014cited by this paper
• Chronic rejection in vascularized composite allografts

  2014cited by this paper
• Histopathology of Chronic Rejection in a Nonhuman Primate Model of Vascularized Composite Allotransplantation

  2013cited by this paper
• Upper-Extremity Transplantation Using a Cell-Based Protocol to Minimize Immunosuppression

  2013cited by this paper
• Review of the Early Diagnoses and Assessment of Rejection in Vascularized Composite Allotransplantation

  2013cited by this paper
• Vascularized composite allotransplantation: towards tolerance and the importance of skin-specific immunobiology

  2013cited by this paper
• Vascularized Osteomyocutaneous Allografts Are Permissive to Tolerance by Induction‐Based Immunomodulatory Therapy

  2013cited by this paper
• Split Rejection in Vascularized Composite Allotransplantation

  2013cited by this paper
• Simultaneous Bone Marrow and Composite Tissue Transplantation in Rats Treated With Nonmyeloablative Conditioning Promotes Tolerance

  2013cited by this paper
• Impact of donor-specific antibodies in reconstructive transplantation

  2013cited by this paper
• A Critical Analysis of Rejection in Vascularized Composite Allotransplantation: Clinical, Cellular and Molecular Aspects, Current Challenges, and Novel Concepts

  2013cited by this paper
• Mechanisms of rejection: current perspectives.

  2012cited by this paper
• Phenotypes of antibody‐mediated rejection in organ transplants

  2012cited by this paper
• Graft Vasculopathy in Clinical Hand Transplantation

  2012cited by this paper
• Biologics and donor bone marrow cells for targeted immunomodulation in vascularized composite allotransplantation: a translational trial in swine.

  2011cited by this paper
• Vascularized Bone Marrow‐Based Immunosuppression Inhibits Rejection of Vascularized Composite Allografts in Nonhuman Primates

  2011cited by this paper
• Humoral autoimmunity and transplant vasculopathy: when allo is not enough.

  2010cited by this paper
• Composite Tissue Vasculopathy and Degeneration Following Multiple Episodes of Acute Rejection in Reconstructive Transplantation

  2010cited by this paper
• Molecular Markers and Targeted Therapy of Skin Rejection in Composite Tissue Allotransplantation

  2010cited by this paper
• Immune Responses Elicited in Tertiary Lymphoid Tissues Display Distinctive Features

  2010cited by this paper
• Presensitized kidney graft recipients with HLA class I and II antibodies are at increased risk for graft failure: a Collaborative Transplant Study report.

  2009cited by this paper
• De Novo Donor‐Specific Antibody at the Time of Kidney Transplant Biopsy Associates with Microvascular Pathology and Late Graft Failure

  2009cited by this paper
• Antiangiogenic Treatment Prevents Adventitial Constrictive Remodeling in Graft Arteriosclerosis

  2008cited by this paper
• The Banff 2007 Working Classification of Skin‐Containing Composite Tissue Allograft Pathology

  2008cited by this paper
• Outcomes 18 months after the first human partial face transplantation.

  2007cited by this paper
• Absence of c4d deposition in human composite tissue (hands and face) allograft biopsies: an immunoperoxidase study.

  2007cited by this paper
• Chronic Allograft Nephropathy: Current Concepts and Future Directions

  2006cited by this paper
• Response to Comment on “The Vast Majority of CLA+ T Cells Are Resident in Normal Skin”

  2006cited by this paper
• The Vast Majority of CLA+ T Cells Are Resident in Normal Skin1

  2006cited by this paper
• The inflammasome: first line of the immune response to cell stress.

  2006cited by this paper
• Lymphoid Neogenesis in Murine Cardiac Allografts Undergoing Chronic Rejection

  2005cited by this paper
• Split tolerance to a composite tissue allograft in a swine model

  2003cited by this paper
• Chronic Rejection after Human Liver Transplantation

  2002cited by this paper
• Allogeneic bone marrow transplantation with co-stimulatory blockade induces macrochimerism and tolerance without cytoreductive host treatment

  2000cited by this paper
• Relative Antigenicity of Components of a Vascularized Limb Allograft

  1991cited by this paper
• T cell subsets in allograft rejection. In situ characterization of T cell subsets in human skin allografts by the use of monoclonal antibodies.

  1982cited by this paper
• Rejection of first-set skin allografts in man. the microvasculature is the critical target of the immune response

  1979cited by this paper

• Nail abnormalities in upper extremity transplantation: Perspectives and insights from systemic diseases and organ transplantation.

  2026cites this paper
• A systematic review of treatment strategies to combat acute and chronic rejection episodes in vascularized composite allotransplantation

  2026cites this paper
• Sentinel flaps reflect key inflammatory aspects of human face transplant rejection.

  2025cites this paper
• Analyzing the candidate pool for Vascularized Composite Allotransplantation - A multi-center OPTN study with a focus on face transplant candidates.

  2025cites this paper
• Unraveling the Roles of Macrophages in Vascularized Composite Allotransplantation

  2025cites this paper
• Chronic rejection models for vascularized composite tissue allotransplantation

  2025cites this paper
• Immunologic Pretreatment of Donor Tissue in Vascularized Composite Allotransplantation: A Systematic Review.

  2025cites this paper
• New Paradigms in Rejection Monitoring: Lymphocyte Subsets as Noninvasive Graft Markers in Vascularized Composite Allotransplantation

  2025cites this paper
• Multi-Center Outcome Analysis of 16 Face Transplantations – A Retrospective OPTN Study

  2025cites this paper
• The future role of mitochondrial drugs in vascularized composite allotransplantation: A short review

  2025cites this paper
• Tacrolimus-loaded Drug Delivery Systems in Vascularized Composite Allotransplantation: Lessons and Opportunities for Local Immunosuppression

  2024cites this paper
• Emerging strategies for tissue engineering in vascularized composite allotransplantation: A review

  2024cites this paper
• Machine Perfusion Enables 24-h Preservation of Vascularized Composite Allografts in a Swine Model of Allotransplantation

  2024cites this paper
• Vascular changes in vascularized composite allotransplantation

  2024cites this paper
• [Advances and perspectives in vascularized composite allotransplantation preservation].

  2024cites this paper
• Continuous oxygen monitoring to enhance ex-vivo organ machine perfusion and reconstructive surgery.

  2024cites this paper
• VCA supercooling in a swine partial hindlimb model

  2024cites this paper
• Supercooling: a promising technique for prolonged preservation in solid organ transplantation, and early perspectives in vascularized composite allografts

  2023cites this paper
• Cellular activation pathways and interaction networks in vascularized composite allotransplantation

  2023cites this paper
• Challenges and opportunities in vascularized composite allotransplantation of joints: a systematic literature review

  2023cites this paper
• The Effects of Growth Hormone on Nerve Regeneration and Alloimmunity in Vascularized Composite Allotransplantation

  2023cites this paper
• Novel Human Umbilical Di-Chimeric (HUDC) cell therapy for transplantation without life-long immunosuppression

  2023cites this paper
• Ushering in the era of regenerative surgery.

  2023cites this paper
• Non-HLA Antibodies in Hand Transplant Recipients Are Connected to Multiple Acute Rejection Episodes and Endothelial Activation

  2022influential citation
• Regulatory T Cells: Liquid and Living Precision Medicine for the Future of VCA

  2022cites this paper
• Immunoregulatory and lipid presentation pathways are upregulated in human face transplant rejection.

  2021influential citation
• Noninvasive evaluation of intragraft immune responses in upper extremity transplantation

  2021cites this paper
• Engineering L-tyrosine based polycarbonate copolymers as degradable devices for long-term, localized delivery of hydrophobic macrolide immunosuppressants to prevent transplant rejection

  2021cites this paper
• Facial Trauma 8 years after a Face Transplantation

  2021cites this paper
• Randomized preclinical study of machine perfusion in vascularized composite allografts

  2020cites this paper
• Trauma-induced Rejection in Vascularized Composite Allotransplantation.

  2020cites this paper
• Abnormal Nailfold Capillaries in Patients after Hand Transplantation

  2020cites this paper
• A chronic rejection model and potential biomarkers for vascularized composite allotransplantation

  2020cites this paper
• The engraftment dynamics evaluation of skin grafts via aluminium phthalocyanine nanoparticles using spectroscopic methods

  2019cites this paper
• Genitourinary vascularized composite allotransplantation: a review of penile transplantation.

  2019cites this paper
• A Skin Rejection Grading System for Vascularized Composite Allotransplantation in a Preclinical Large Animal Model

  2019cites this paper
• Aesthetic/Cosmetic Surgery and Psychiatry

  2018cites this paper
• Advances in machine perfusion, organ preservation, and cryobiology: potential impact on vascularized composite allotransplantation

  2018cites this paper
• The concept of the portable spectrometer for fast assessment of skin engraftment via exogenous and endogenous fluorophores

  2018cites this paper
• World Journal of Transplantation

  year unknowncites this paper